From higher drug prices to lifetime caps on Medicaid, this agenda is a recipe for disaster on the health front.

This year has seen a double dose of optimism in the field of HIV prevention. First, on 20 June 2024, came the results of the Purpose-1 trial in South Africa and Uganda.1 This randomised controlled ...

Gilead Sciences’s decision to distribute HIV prevention drug lenacapavir made the news this month when they signed ...

In June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. A ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

A photograph allegedly showing Diana, Princess of Wales, in 1991 shaking hands with a man diagnosed with HIV/AIDS — at a time ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

A new feature film chronicling the life of South African transgender icon Granny Lee is due to begin production in ...

Since 1985, the event has shed a light on a virus that affects over 1.2 million people in the U.S. and nearly 58,000 in L.A.

In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...

"This was worse than our national election." -- Eric Peterson, MD, MPH, cardiologist and FDA advisory committee member, ...